Golin Promotes Jaimee Reggio to Managing Director, Golin U.S. Healthcare

May 5, 2021

Jaimee Reggio sitting and smiling Jaimee Reggio sitting and smiling

Reggio to oversee the region’s blue chip client roster and lead growth for the practice  

CHICAGO (May 5, 2021) – Interpublic Group (NYSE: IPG) agency Golin announced today the appointment of Jaimee Reggio to managing director of U.S. healthcare. Based in Golin’s headquarter market of Chicago, she officially started the newly created role last quarter.

Reggio brings two decades of pharmaceutical and healthcare experience to this role, spending the last 12 years at Golin leading the healthcare practice’s largest pharmaceutical businesses and contributing to year-over-year growth. Reggio most recently led the agency’s largest healthcare practice in its headquarter market of Chicago.

Last year was a pivotal year for Golin healthcare. The agency earned double digit growth across the U.S. with organic and new client wins, it prioritized investments within healthcare communications and hired specialty talent to strengthen client service.

“I can’t imagine a more exciting time to be in healthcare supporting our clients across the industry in bringing forth innovative treatments and solutions to meet the evolving needs of patients,” said Reggio. “I am so proud of the real impact our team is making in partnership with our clients, especially now when the needs are so great across the board.”

As part of her first charge, Reggio plans to operationalize client delivery and service during a time of continued growth and leadership transition for the practice and create a stronger offering that sets Golin healthcare on the path toward long-term success. She’ll also foster and build a team that expands the agency’s speciality capabilities, identify best practices and improve internal systems with an eye toward future needs and budget realities.

With Reggio’s expanded role, Golin also grew its leadership bench by welcoming Elizabeth Fisher-Au from fellow IPG DXTRA agency, WeberShandwick, to be executive vice president, healthcare and lead Golin’s growing Janssen portfolio.